✦ LIBER ✦

PAR22 COST-EFFECTIVENESS OF RITUXIMAB (MABTHERA) COMPARED WITH ABATACEPT (ORENCIA) FOR THE TREATMENT OF MODERATE/SEVERE RHEUMATOID ARTHRITIS (RA) IN THE UNITED KINGDOM

✍ Scribed by G Lewis; A Kielhorn; A Diamantopoulos

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS25 COST-EFFECTIVENESS OF RITUXIMAB (M

✍ R Plisko; J Krzystek; P Rys; M Russel-Szymczyk; M Szkultecka-Debek; K Szamotulsk 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Indirect cost-effectiveness analyses of

✍ Yuan, Yong; Trivedi, Digisha; Maclean, Ross; Rosenblatt, Lisa 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 488 KB

PMS31 Cost-Effectiveness of Abatacept fo

✍ L. Pericleous; M. Lebmeier 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PMS54 COST-EFFECTIVENESS OF TOCILIZUMAB

✍ Diamantopoulos, A; Wintfeld, N; Giuliani, G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PMS21 COST—EFFECTIVENESS OF RITUXIMAB VS

✍ LA Bynum; N Joshi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PMS29 CANADIAN COST-EFFECTIVENESS ANALYS

✍ D Zou; O Desjardins; N Tsao; R Goeree 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB